About Renjie

Renjie focuses on securities and corporate transactions, including Hong Kong initial public offerings (IPOs), compliance and corporate governance of HKEX-listed companies. He has broad experience in Hong Kong IPOs, representing both issuers and underwriters.

Renjie is a native Mandarin speaker and is fluent in English.

Representative matters:

IPOs

  • PATEO in its HK$1.07 billion Hong Kong IPO and global offering
  • UBS and CICC in Joyson Electronic’s US$4.37 billion Hong Kong IPO and global offering*
  • Innogen Pharmaceutical in its HK$683 million Hong Kong IPO and global offering
  • Breton Technologyin its HK$234 million Hong Kong IPO and global offering
  • Morgan Stanley and CICC in Taimei Technology’s HK$335 million Hong Kong IPO and global offering
  • CICC and SPDBI in BrainAurora Medical’s HK$538 million Hong Kong IPO and global offering
  • Haitong International in Qunabox Group’s HK$493 million Hong Kong IPO and global offering
  • YZY Biopharma in its HK$176 million Hong Kong IPO and global offering

HKEX compliance

  • YZY Biopharma
  • YH Entertainment
  • Asymchem

* Representation handled before joining Cooley

Download full bio

Education

  • China University of Political Science and Law
    LLB
  • Tsinghua University
    Juris Master